Anna Sussman | VP, IR and Corporate Communications |
Patrick Mahaffy | President and CEO |
Thomas Harding | Chief Scientific Officer |
Dan Muehl | CFO |
Charlie Ferranti | Goldman Sachs |
Good morning. And welcome to the Clovis Oncology First Quarter 2022 Operating Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions].